| Customization: | Available |
|---|---|
| Application: | Internal Medicine |
| Usage Mode: | IV |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name | Furosemide injection |
| Product Type | HUMAN PRESCRIPTION DRUG LABEL |
| Route of Administration | Intramuscularly, intravenously |
| 1. Dosage: | 20mg 2ml |
| 2. Quality standard | BP or CP |
| 3. Packaging: | 100amps/box |
| 4. Storage | below 25ºC Airtight Storage |
| 5. Period of validity | 3 years |
OEM GMP Factory Furosemide Injection 20mg/2ml human medicine Circulatory System
ndicatios:
Furosemide is a potent diuretic and is recommended for use when prompt and effective diuresis is required. Furosemide Injection 20mg/2ml is appropriate for use in emergencies or where oral therapy is not feasible. The indications include cardiac, pulmonary, hepatic and renal oedema.
Dosage and administration:
Posology
Furosemide Injection 20mg/2ml
Adults: Initially, doses of 20 - 50mg may be administered by the intramuscular route, or by slow intravenous injection at a rate not exceeding 4mg/minute. The diuretic effect of furosemide is proportional to the dosage and, if larger doses are required, they should be given as a controlled infusion at a rate not exceeding 4mg/minute and titrated according to the response.
Elderly: Elimination of furosemide is generally slower in the elderly. Dosage should be titrated until the required effect is achieved.
Paediatric population: Dosages for children range from 0.5 - 1.5mg/kg weight daily up to a maximum total daily dose of 20mg. Method of administration
Furosemide Injection 20mg/2ml is for intramuscular or for intravenous administration and must always be given slowly.
Contraindications:
Hypersensitivity to the active substance or to any of the excipients
Hypersensitivity to amiloride, sulphonamides or sulphonamide derivativesHypovolaemia and dehydration (with or without accompanying hypotension)
Severe hypokalaemia: severe hyponatraemia
Comatose or pre-comatose states associated with hepatic cirrhosis
Anuria or renal failure with anuria not responding to furosemide, renal failure as a result of poisoning by nephrotoxic or hepatotoxic agents, renal failure associated with hepatic coma Impaired renal function with a creatinine clearance below 30ml/min per 1.73 m2 body surface area
Addison's disease
Digitalis intoxication
Porphyria
Breast-feeding women
Storage:
Keep in outer carton
Do not store above 25°C
Do not refrigerate or freeze.
){kind=link}